|
R&D Pipeline News Vol. 2, Issue 24: Johnson & Johnson: full development pipeline |
|
|
|
26 Jun 2006 |
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Project Pipeline List .
 |
| |
Special Company Pipeline:
Featured Pipelines:
|
Vol. 2 Issue nº 24 June 26, 2006
|
  |
|
|
Special Company Pipeline:
|
Johnson & Johnson: full development pipeline
|
|
|
|
Featured Pipelines
|
Pipeline Update: Thrombolytics
|
- ImaRx acquired all thrombolytic projects from Abbott;
- Innovative combinations of thrombolytic with ultrasound;
- New uses of thrombolytics for cancer and visual disorders;
- Strong interest in thrombolytics which directly lyse fibrin;
- Plasmin and microplasmin as novel thrombolytics
- No biogeneric thrombolytics in Europe , but plenty in emerging markets;
- Biogenerics include rec streptokinase, t-PA, tenecteplase and reteplase.
More Details inside R&D Pipeline News Get you annual subscription and receive this issue for free!
|
Product Pipeline: female sexual arousal disorder (FSAD)
|
- Most development projects use testosterone;
- Significant improvements of FSAD achieved with testosterone patch in phase III;
- New class of centrally acting sexual stimulants
- Pan-melanocortin receptor agonist in advanced phase II for FSAD;
- Also evaluated in male erectile dysfunction
- Topical prostaglandins in advanced clinical development
More Details inside R&D Pipeline News Get you annual subscription and receive this issue for free!
|
|
R&D Pipeline News Get your Subscription Now
|
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products. Read more about R&D Pipeline NewsOrder Now
 
|
|
|
|
|
|
|
|
|